Image

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Recruiting
18 years and older
All
Phase 2

Powered by AI

Overview

To learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is radiation therapy given to the area around your spine.

Description

Primary objective:

• To determine the 6-month local control (LC) of the target site of treatment.

Secondary Objectives:

  • To determine the 6-month change in epidural tumor volume (by volumetric measurements where applicable)
  • To determine the 1-year local control of the target site

Eligibility

INCLUSION CRITERIA:

  1. Age ≥ 18 years old
  2. Radiographically documented disease of the spine within 4 weeks of registration (candidates with or without epidural disease allowed)
  3. Candidate for spine SRS/SBRT as determined by treating Radiation Oncologist or Multidisciplinary Spine Conference review
  4. Maximum of 3 contiguous vertebral levels involved with metastasis in the spine to be irradiated allowed
  5. Diagnosis of cancer documented
  6. Motor strength ≥ 4 out of 5 in the extremity affected by the level of spinal disease planned for radiation
  7. Karnofsky Performance score (KPS) ≥ 40 or ECOG score ≤ 3

EXCLUSION CRITERIA:

  1. Patients with highly radiosensitive histologies likely to respond to conventional radiation therapy alone (ie lymphoma, multiple myeloma, etc)
  2. Patients who are unable to undergo MRI of the spine with contrast
  3. Patients who are pregnant

Study details
    Spinal Disease

NCT05709782

M.D. Anderson Cancer Center

16 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.